无动脉和手术后心房动:来自倾向匹配队列研究的五年结果
Thomas French1, Sanjeet Singh Avtaar Singh2,3, Vincenzo Giordano2
1Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, United Kingdom. thomfren12@gmail.com.
World journal of cardiology
|May 1, 2025
概括
无的Perceval提供了安全高效的外科动脉置换 (SAVR) 替代方案,减少了高风险患者的手术时间和肺炎和心房动的风险. 然而,较大的门尺寸与死亡风险增加有关.
科学领域:
- 心血管外科心血管外科
- 生物假体门的使用方法
- 外科手术的结果
背景情况:
- 珀塞瓦尔索林S门是高风险患者的无生物假体选择,不适合传统的大动脉门置换 (AVR).
- 它可以作为跨导管大动脉植入和传统外科AVR的替代方案.
研究的目的:
- 为了比较五年隔离AVR的术后结果,使用Perceval与 sutured生物假体相比.
- 评估无AVR在高风险手术队列中的安全性和有效性.
主要方法:
- 在一个单一的高等中心进行回顾性队列研究 (2017-2023年).
- 匹配了来自982名确定的患者的174个佩尔塞瓦尔置换器与174个接置换器.
- 进行对比的队列特征,手术期间的细节和手术后的结果.
主要成果:
- 感应组显著减少了主动脉交叉,心肺绕道和总手术时间 (P < 0.001).
- 在Perceval组中观察到手术后肺炎 (OR=0.53) 和心房动 (OR=0.58) 的风险较低.
- 在5年后的倾向匹配后,所有原因的死亡率没有显著差异;然而,较大的门大小增加了死亡风险 (P=0.020).
结论:
- 无手术AVR (SAVR) 是接SAVR的安全有效替代方案,有可能减少术后心房动.
- 无动脉门过大与不良的临床结果有关.
- 缩短心肺旁路时间为高危患者的治疗提供了便利.
更多相关视频
14:14Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
13.9K
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
3.3K
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
